Trial intelligence / Profile preview

Decitabine in Locally Advanced Nasopharyngeal Carcinoma

NCT03701451Phase 2Unknown

Start
Feb 2018
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of decitabine in nasopharyngeal carcinoma (NPC). Status: unknown.

02

Drugs

decitabine
03

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT03701451.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03701451.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call